AstraZeneca (($AZN)) has held its Q3 earnings call. Read on for the main highlights of the call. AstraZeneca’s recent earnings call showcased a ...

Under the model, set to start next year, the CMS will negotiate lower prices for Medicaid programs linked to those paid in ...

The condition, which most often affects people in warm, humid climates where fungal spores are common, can trigger nasal ...

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

Pharma’s push into direct-to-patient sales is reshaping the front end of drug distribution, but wholesalers like Cencora, McKesson, and Cardinal Health remain indispensable as the backbone of the ...

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

Eli Lilly and Novo Nordisk have agreed pricing deals for GLP-1RA brands, a pivotal moment in the obesity treatment market.

Experts hail the ‘very exciting” discovery that the oft-observed protection against triple-negative breast cancer afforded by breastfeeding may be due to resident T cells left behind in the breast.

A single-inhaler triple therapy improved lung function in adults and adolescents with inadequately controlled asthma and was ...

Drugmakers feel empowered to resist foreign price controls — confident that the Trump administration will have their backs.

Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...